CJ-30002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CJ-30002, covering 2013-02-15 to 2013-02-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients [Phase 3]